Therefore, it is of great significance to identify EGFR palmitoylase and depalmitoylase and clarify the regulatory mechanism of EGFR palmitoylation in different cancer types and different mutant environments for personalized treatment of cancer patients. This evidence concerns the gene EGFR and cancer.